Cambridge Investment Research Advisors »

Lyra Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $259k 42k 6.23

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Lyra Therapeutics

Perceptive Advisors
Nantahala Capital Management
Point72 Asset Management
Citadel Advisors
Samsara BioCapital
VR Adviser
Ikarian Capital
Rosalind Advisors
Vanguard Group
Susquehanna International
Millennium Management
Alyeska Investment Group
Bank of America Corporation
Two Sigma Investments
Citigroup

View all funds holding Lyra Therapeutics